beta

ALRN

Aileron Therapeutics Inc.

Alrn

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Aileron Therapeutics Inc is a clinical-stage biopharmaceutical company that is focused on developing and commercializing a novel class of therapeutics called stapled peptides.

Market Cap: 139 Million

Primary Exchange: NASDAQ Global Market

Website: http://www.aileronrx.com

Shares Outstanding: 14.7 Million

Float: 14.1 Million

Dividend: 0.0 (0.0%)

Beta: -179.377319

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 51.8 Thousand

Ethical Flags

Animal testing

Longest drawdown: 506 trading days

From: 2017-10-04 To: 2019-10-16

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud